Kaleido Biosciences

NASDAQ

KLDO

$0.0001 0.0000 0.0000%

Today share price

About company

Company Description

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of immuno-oncology, and cardiometabolic and liver diseases. The company has collaboration agreements with Gustave Roussy Cancer Center, Washington University School of Medicine, and Janssen. It also has a strategic collaboration with the COPD Foundation to study KB109 in patients with chronic obstructive pulmonary disease. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

USA

Sector: Healthcare Industry: Pharmaceuticals

Get access
to the rating of Finrange stocks

With this tariff you will be able to use the service without restrictions, all information will be available

Get 7 days free

Rating Finrange

Index: 7.5 %

Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

4.19K

EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

4.19K

Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

37.04

Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

41.86M

YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.